|
|
 Previous Article | Table of Contents | Next Article 
A cysteine protease inhibitor prevents activation-induced T-cell apoptosis
and death of peripheral blood cells from human immunodeficiency
virus-infected individuals by inhibiting upregulation of Fas ligand
Y Yang, ZH Liu, CF Ware and JD Ashwell
Laboratory of Immune Cell Biology, National Cancer Institute, Bethesda, MD
20892-1152, USA.
Activation of T-cell hybridomas, preactivated normal T cells, and
peripheral blood lymphocytes (PBL) from human immunodeficiency virus
(HIV)-infected individuals results in apoptosis. In the first two cases,
apoptosis is caused by the upregulation of Fas ligand (FasL) and its
subsequent interaction with Fas; the mechanism for the spontaneous and
activation-induced death of lymph node cells and PBL from HIV+ blood is not
known. A number of protease inhibitors have been shown to prevent T-cell
apoptosis under all of these circumstances, but the mechanism of action has
not been determined. Here we show that the cysteine protease inhibitor E64d
prevent activation-induced T hybridoma cell death by inhibiting the
upregulation of FasL. Quantitative polymerase chain reaction (PCR)
demonstrated that mRNA for FasL is expressed at low levels in fresh PBL
from HIV-infected blood, but increases in cultured PBL from both uninfected
and HIV-infected donors. The ex vivo apoptosis of PBL from HIV+ donors was
prevented by adding the soluble extracellular domain of Fas, demonstrating
a requisite role for Fas/ FasL interactions in this form of cell death.
Furthermore, while having no effect on the death of PBL from HIV-infected
blood stimulated directly via Fas, E64d inhibited FasL upregulation. Thus,
aberrant apoptosis of cultured PBL from HIV-infected individuals is
mediated by FasL and Fas, and E64d blocks this apoptosis by inhibiting the
upregulation of FasL. These results are consistent with the hypothesis that
the abnormal expression of Fas and the inducible expression of FasL,
contributes to the immunodeficiency of patients with acquired immune
deficiency syndrome and suggest that modulation of FasL expression could be
an effective target for therapeutic intervention.
Volume 89,
Issue 2,
pp. 550-557,
01/15/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Tsubokawa, I. Solaroglu, H. Yatsushige, J. Cahill, K. Yata, and J. H. Zhang
Cathepsin and Calpain Inhibitor E64d Attenuates Matrix Metalloproteinase-9 Activity After Focal Cerebral Ischemia in Rats
Stroke,
July 1, 2006;
37(7):
1888 - 1894.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Altznauer, S. Conus, A. Cavalli, G. Folkers, and H.-U. Simon
Calpain-1 Regulates Bax and Subsequent Smac-dependent Caspase-3 Activation in Neutrophil Apoptosis
J. Biol. Chem.,
February 13, 2004;
279(7):
5947 - 5957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Sade, S. Krishna, and A. Sarin
The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells
J. Biol. Chem.,
January 23, 2004;
279(4):
2937 - 2944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Estaquier, J.-D. Lelievre, F. Petit, T. Brunner, L. Moutouh-de Parseval, D. D. Richman, J. C. Ameisen, and J. Corbeil
Effects of Antiretroviral Drugs on Human Immunodeficiency Virus Type 1-Induced CD4+ T-Cell Death
J. Virol.,
May 13, 2002;
76(12):
5966 - 5973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Lenardo, S. B. Angleman, V. Bounkeua, J. Dimas, M. G. Duvall, M. B. Graubard, F. Hornung, M. C. Selkirk, C. K. Speirs, C. Trageser, et al.
Cytopathic Killing of Peripheral Blood CD4+ T Lymphocytes by Human Immunodeficiency Virus Type 1 Appears Necrotic rather than Apoptotic and Does Not Require env
J. Virol.,
April 16, 2002;
76(10):
5082 - 5093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. de Oliveira Pinto, S. Garcia, H. Lecoeur, C. Rapp, and M.-L. Gougeon
Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3
Blood,
March 1, 2002;
99(5):
1666 - 1675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Somma, L. Tuosto, M. S. G. Montani, M. M. Di Somma, E. Cundari, and E. Piccolella
Engagement of CD4 Before TCR Triggering Regulates Both Bax- and Fas (CD95)-Mediated
J. Immunol.,
May 15, 2000;
164(10):
5078 - 5087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kinoshita and K. Shimokado
Autocrine FGF-2 Is Responsible for the Cell Density-Dependent Susceptibility to Apoptosis of HUVEC : A Role of a Calpain Inhibitor-Sensitive Mechanism
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1999;
19(10):
2323 - 2329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Bohler, K.-M. Debatin, R. Linde;, S. Pahwa, and T. W. McCloskey
Sensitivity of CD4+ Peripheral Blood T Cells Toward Spontaneous and CD95 (APO-1/Fas)-Induced Apoptosis in Pediatric Human Immunodeficiency Virus Infection
Blood,
September 1, 1999;
94(5):
1829 - 1833.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-N. Xu, B. Laffert, G. R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A. J. McMichael, and A. S. Baur
Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor zeta Chain
J. Exp. Med.,
May 3, 1999;
189(9):
1489 - 1496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. McCloskey, S. Bakshi, S. Than, P. Arman, and S. Pahwa
Immunophenotypic Analysis of Peripheral Blood Mononuclear Cells Undergoing In Vitro Apoptosis After Isolation From Human Immunodeficiency Virus-Infected Children
Blood,
December 1, 1998;
92(11):
4230 - 4237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Mittelstadt and J. D. Ashwell
Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression
Mol. Cell. Biol.,
July 1, 1998;
18(7):
3744 - 3751.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Woo, R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kägi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, et al.
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
Genes & Dev.,
March 15, 1998;
12(6):
806 - 819.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. Bohler, I. Herr, K.-M. Debatin, M. Geiss, J. Haas;, Y. Yang, J. D. Ashwell AUTHOR=Naoki Hosaka, and S. Pahwa
Downregulation of Increased CD95 (APO-1/Fas) Ligand in T Cells From Human Immunodeficiency Virus-Type 1-Infected Children After Antiretroviral Therapy
Blood,
July 15, 1997;
90(2):
886 - 887.
[Full Text]
[PDF]
|
|
|
|
|
